Peer Review History
| Original SubmissionNovember 20, 2024 |
|---|
|
Dear Dr. Smith, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Mar 24 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Jagadeesh Puvvula, PhD, PharmD, MPH Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following financial disclosure: “This work was supported by the National Institute of Environmental Health Sciences [R01ES030994: SOLAir: Environmental Factors and Diabetes Development in Latinos]; And the National Institute of Health [5P30ES007033: Interdisciplinary Center for Exposures, Diseases, Genomics, and Environment (EDGE Center)]. Awards received by JK. https://www.niehs.nih.gov/funding/grants https://www.nih.gov/grants-funding The Hispanic Community Health Study/Study of Latinos is a collaborative study supported by contracts from the National Heart, Lung, and Blood Institute (NHLBI) to the University of North Carolina (HHSN268201300001I / N01-HC-65233), University of Miami (HHSN268201300004I/N01-HC-65234), Albert Einstein College of Medicine (HHSN268201300002I / N01-HC-65235), University of Illinois at Chicago (HHSN268201300003I / N01- HC-65236 Northwestern Univ), and San Diego State University (HHSN268201300005I / N01-HC-65237). The following Institutes/Centers/Offices have contributed to the HCHS/SOL through a transfer of funds to the NHLBI: National Institute on Minority Health and Health Disparities, National Institute on Deafness and Other Communication Disorders, National Institute of Dental and Craniofacial Research, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Neurological Disorders and Stroke, NIH Institution-Office of Dietary Supplements. https://www.nhlbi.nih.gov/grants-and-training/funding-opportunities-and-contacts This publication was developed under a STAR research assistance agreements, No. RD831697 (MESA Air) and RD-83830001 (MESA Air Next Stage), awarded by the U.S Environmental Protection Agency. It has not been formally reviewed by the EPA. The views expressed in this document are solely those of the authors and the EPA does not endorse any products or commercial services mentioned in this publication. Awards received by JK. https://www.federalgrantswire.com/science-to-achieve-results-star-program.html” Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 3. We note that you have indicated that there are restrictions to data sharing for this study. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Before we proceed with your manuscript, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible. We will update your Data Availability statement on your behalf to reflect the information you provide. 4. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** Reviewer #1: I have reviewed this manuscript thoroughly and can confirm that it is technically sound, with relevant supporting data. It is written in clear and simple language, making it easy to understand. However, there are a few minor grammatical errors, and I recommend that the authors proofread the manuscript and address these issues. Reviewer #2: Good effort by the authors The utilization of a large well-established cohort is commendable and also targeting an underrepresented group in diabetes research, in 4 major US metropolitan areas. line 105-109: ''This NE WAS investigated the association between hundreds of neighborhood environment variables linked to residential address and incident diabetes approximately 6 years later. We also used factor analysis to identify patterns in features of the same suite of variables as predictors of risk, in the population-based Hispanic Community Health Study / Study of Latinos'' . This sentences is not required as part of the introduction. Rather, it should be found in the methods section. The weighted average age was 39.2 years old. This suggest most of the participants are younger. what proportion of are adult above 65 years old? It was reported that the IRR was adjusted for age. Was any thought given to the impact of retrospective exposures of some of the the participants in the environment/neighborhood measures? In Table 3. Neighborhood measures significantly associated with incident T2D (including self report) with an FDR adjustment at the p < 0.05 level in age and sex adjusted models, the Tract level % aged 18 to 64 seemed not represented. Any explanation for this? Line 306: "Contrary to our results, previous research has linked neighborhood environment and neighborhood socioeconomic constructs to T2D [15,16,28]." In addition to the fact that previous studies on neighborhood environment and incident T2D clustered related neighborhood measures into a single variable: were those previous study longitudinal? and what was the duration of the study/observations? could this have also contributed to the difference in the results from this and previous studies? Considering desire to have more impactful effect on a person/population, is this study continuous? Reviewer #3: The authors use an interesting approach here, applying big data and GWAS principles to evaluate neighborhood environment factors associated with T2D. The statistical analyses are sound and conclusions are supported by the reported results. The main weakness of the paper is a lack of discussion regarding selection bias. I would suggest the authors evaluate what the 'general' Hispanic/Latino population looks like in these cities and nationwide, what fraction of them has T2D, neighborhood environment characteristics of areas with Hispanic/Latino population, and how all of this compares to the study populations in the 4 cities. Without this, the generalization of the results are gravely hampered. Even though individual information regarding risk factors will not be available for this evaluation, population level risk factors may offer suggestions as to whether the conclusions from this report are generalizable and in what parts of country (if any). Other comments: 1) The authors' discussion of people who 'moved' between baseline and visit 2 was also confusing. I would suggest they clarify this point further. 2) Instead of looking for environmental factors that are as strong or stronger than individual factors, I would suggest the authors consider neighborhood environment factors as potential moderators of the relationship between personal risk factors and T2D. This possibility needs to be addressed. 3) Another key factor that deserves discussion is the level of interaction an individual has with their home environment. For instance, some people may interact more with the neighborhood environmental factors at their workplace than home location. This should be considered in Limitations section, along with other personal factors related to physical/mental health, occupation, lifestyle factors, free time, etc. that may influence how a person interacts with their environment in a way that can meaningfully impact their risk of developing T2D. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
<p>Neighborhood Environment and Incident Diabetes, A Neighborhood Environment-Wide Association Study (‘NE-WAS’): Results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) PONE-D-24-39866R1 Dear Dr. Smith, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Kamran Baig, MPH, MBBS Academic Editor PLOS ONE Additional Editor Comments (optional): Thank you for your thoughtful revisions to your manuscript. This have further enhanced the clarity and scientific rigor. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #2: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #2: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #2: Yes Reviewer #3: Yes ********** Reviewer #2: Previous comment are well addressed. With the review done, the knowledge value of the manuscript has been enhanced. Looking forward to future outcomes from the study. Reviewer #3: Authors have done a commendable job with the revisions. I believe it is improved because of their efforts. I have no further comments on this manuscript. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #2: No Reviewer #3: No ********** |
| Formally Accepted |
|
PONE-D-24-39866R1 PLOS ONE Dear Dr. Smith, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Kamran Baig Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .